Effect of Acute Nitrate Supplementation on Vascular Function in Hispanic, Black and White Population
Launched by UNIVERSITY OF TEXAS AT AUSTIN · Jan 7, 2022
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different groups of healthy adults—specifically Hispanic, Black, and White individuals—respond to a type of supplement called Beetroot juice and how it affects their blood vessels. The goal is to learn more about how race and ethnicity might influence heart health and the function of blood vessels. Researchers want to better understand these differences to improve cardiovascular health for everyone.
To participate in this study, you need to be a healthy adult aged between 18 and 75 and belong to one of the three racial groups mentioned. However, people with high blood pressure, a high body mass index (BMI), or certain health conditions like heart disease, as well as smokers and pregnant individuals, cannot join. If you decide to participate, you can expect to take Beetroot juice and undergo tests to measure how well your blood vessels are working. This study is currently recruiting participants, and your involvement could help contribute valuable information about cardiovascular health across different populations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy men and women who are either Caucasian American, Hispanic, or non-Hispanic African American
- Exclusion Criteria:
- • Blood pressure higher than or equal to 140/90 mmHg
- • BMI \> 35kg/m2
- • Have a history of cardiovascular, neurological or vascular diseases
- • Take prescription medications
- • Are smokers
- • Are pregnant
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials